• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER CONSTELLATION VISION SYSTEM; UNIT, PHACOFRAGMENTATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER CONSTELLATION VISION SYSTEM; UNIT, PHACOFRAGMENTATION Back to Search Results
Catalog Number 8065753041
Device Problem Inability to Irrigate (1337)
Patient Problems Hemorrhage/Bleeding (1888); Hyphema (1911); Intraocular Pressure Increased (1937); Visual Impairment (2138); Vitreous Hemorrhage (2143); Eye Pain (4467); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 09/07/2021
Event Type  Injury  
Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event Description
A customer reported that during a surgery an ophthalmic operating console had no infusion in oil removal phase, which resulted in hypotony and suprachoroidal hemorrhage in a patient.Additional information has been requested.Additional information received indicated that the patient was scheduled for a silicon oil removal surgery.The patient had a stable eye with 20/40 vision prior the surgery.The infusion was stopped during oil removal phase about half way through the removal.The surgeon noticed the eye was soft and stopped aspirating with the oil removal cannula.The eye remained collapsed for at least 30 seconds and did not appear to be reinflating.The surgeon kept the infusion pressure up to 60 and still the eye remained soft, but slowly started to reform over the next 30 seconds.There were no error messages on the screen.Though it re-inflated, it remained soft despite the setting of 60.Through the pupil the surgeon could see choroidals forming, but slowly removed the remainder of the oil.The surgeon enter into the eye with light pipe and cutter and had a fairly large choroidal effusion nasally, extending to the disk.The infusion pressure high, removed the cannulas and closed the sclerotomies with suture.At the completion, the globe was slightly firm to palpation.The following day, the patient's vision was hand motions only.The intraocular pressure (iop) was 35.The patient had hyphema, vitreous hemorrhage and 360 degree hemorrhagic choroidals by ultrasound.The patient remained in hand motions with large hemorrhagic choroidals.Additional information received indicating the patient's current condition is unchanged.Additional information received indicating the surgeon completed the surgery and sutured the wounds at the end.The hypotony lasted for about a minute.The patient not yet recovered from the event.She continued to have pain, elevated intraocular pressure (iop).
 
Manufacturer Narrative
The company service representative examined the system and confirmed the reported event of an infusion issue.However, the company service representative was unable to replicate the issue while on-site.As a preventative measure, the system was replaced.The system was then tested and met all product specifications.The system was received, and a visual assessment of the returned sample revealed discoloration and balanced salt solution (bss) residue.The system was calibrated and turned on.No system message was generated after the boot up sequence.The system was tested per standard test procedure (stp) and the complaint was not replicated.The reported event of the patient experiencing suprachoroidal/vitreous hemorrhage, hyphema cannot be confirmed.A system manufacturing device history record (dhr) review was performed prior to product release to ensure that the product was manufactured in compliance with the device master record.Based on the assessment, the product met release criteria.The root cause cannot be determined conclusively.Manufacturer will continue to monitor data for evidence of adverse trending and take further action, as appropriate.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONSTELLATION VISION SYSTEM
Type of Device
UNIT, PHACOFRAGMENTATION
Manufacturer (Section D)
ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER
15800 alton parkway
irvine CA 92618
Manufacturer (Section G)
ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER
15800 alton parkway
irvine CA 92618
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key12575428
MDR Text Key274696706
Report Number2028159-2021-01147
Device Sequence Number1
Product Code HQC
UDI-Device Identifier00380657530410
UDI-Public00380657530410
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K101285
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 03/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number8065753041
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/19/2021
Initial Date Manufacturer Received 09/08/2021
Initial Date FDA Received10/05/2021
Supplement Dates Manufacturer Received02/17/2022
Supplement Dates FDA Received03/11/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/30/2018
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
-
-